1. Home
  2. FORM vs AMRX Comparison

FORM vs AMRX Comparison

Compare FORM & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

HOLD

Current Price

$56.25

Market Cap

4.5B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.37

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORM
AMRX
Founded
1993
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FORM
AMRX
Price
$56.25
$12.37
Analyst Decision
Buy
Buy
Analyst Count
9
4
Target Price
$55.75
$13.25
AVG Volume (30 Days)
654.7K
1.7M
Earning Date
10-29-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.53
0.02
Revenue
$759,313,000.00
$2,934,959,000.00
Revenue This Year
$3.97
$9.99
Revenue Next Year
$10.24
$6.67
P/E Ratio
$104.87
$758.81
Revenue Growth
2.29
9.50
52 Week Low
$22.58
$6.69
52 Week High
$61.10
$12.68

Technical Indicators

Market Signals
Indicator
FORM
AMRX
Relative Strength Index (RSI) 57.28 61.79
Support Level $54.96 $12.12
Resistance Level $60.30 $12.43
Average True Range (ATR) 1.95 0.31
MACD -0.25 -0.04
Stochastic Oscillator 56.44 70.61

Price Performance

Historical Comparison
FORM
AMRX

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: